Search results for: 'philippines otc market'
- Did you mean
- philippines ott market
- philippine ota market
- Related search terms
- Markets & Markets, Synthetic Biology – Global forecast to 2027, 2023. 01
- market analysis of rf energy harvesting technolog
- market analysi of rf energy harvesting technolog
- market+size+of+china's+overseas+marketing+industry
- market 08 00 00 00
-
20 Apr 2017  |  Asia Pacific  |  Market Research
The Philippines Transformational Healthcare Insights, 2016
Current Trends and Challenges Encountered in the Road to Achieving Universal Healthcare Coverage
The Philippines is a part of the Association of Southeast Asian Nations (ASEAN) community and one of the fastest growing healthcare markets in the region. With regard to healthcare, the Philippine Government has been looking at ways to achieve 100% enrolment to PhilHealth by 2020. One of the means is by mandating all Filipinos to enrol to PhilHealt...
$1,500.00
Special Price $1,125.00 save 25 %
-
03 Aug 2015  |  Africa  |  Market Research
China Contract Research Organisation Market
Exploring the Market Landscape and Future Opportunities
The pharmaceutical industry in Ghana and Nigeria is forecast to represent a combined business opportunity of over $3 billion by 2018, propelled by a convergence of changing economic profiles, increased healthcare spending and investment, and increasing incidence of chronic diseases. Market segmentation is done based on products (OTC, generic, and b...
$1,500.00
Special Price $1,125.00 save 25 %
-
06 Nov 2019  |  North America  |  Market Research
Growth Opportunities in Human Microbiome Market, Forecast to 2023
Strategic Collaborations and Stakeholder Awareness Along with Clear Paths to Commercialization will Play a Key Role for Success in the Human Microbiome Market
Interest in the microbiome as a science and industry has exploded over the past decade. Innovations are happening across 3 significant categories for human health benefits: microbiome-based therapeutics, over-the-counter (OTC) dietary supplements, and self-diagnostics/screening. The OTC market is the largest because of the lack of precise regulatio...
$4,950.00
Special Price $3,712.50 save 25 %
-
19 Aug 2022  |  North America  |  Market Research
Global Antibody Therapeutics Growth Opportunities
The Evolution of Next-generation Immuno-oncology Therapies for Multiple Tumor Antigens is Poised to Drive Market Growth
Market growth is likely to be fueled by the growing utilization of cost-effective and efficient continuous manufacturing processes and single-use bioreactors for production, which will also reduce the time between development and commercialization. Favorable regulatory reforms in emerging Asian countries are encouraging the manufacture and introduc...
$2,450.00
Special Price $1,837.50 save 25 %
-
20 Apr 2023  |  Asia Pacific  |  Market Outlook
Asia-Pacific Next-generation Diagnostics Outlook, 2023
The Renewed Focus on Infectious Diseases Outside COVID-9, Oncology, Cardiovascular, Diabetes, and Prenatal Care will Drive Market Growth
The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus o...
$4,950.00
Special Price $3,712.50 save 25 %
-
18 Oct 2024  |  Global  |  Market Research
Image-guided Therapy Market, Global, 2024-2029
Increased Demand for Minimally Invasive Procedures and the Surge in Day Surgeries at Outpatient Facilities are Driving Transformational Growth
The image-guided therapy (IGT) market is growing rapidly, mainly driven by the rising preference for minimally invasive procedures, technological advancements in multimodal imaging, artificial intelligence, the use of software solutions that enable better clinical outcomes, and the high demand for precision medicine in oncology treatment. In additi...
$4,950.00
Special Price $4,207.50 save 15 %
-
05 Apr 2023  |  Asia Pacific  |  Market Outlook
Asia-Pacific Pharmaceutical Industry Outlook, 2023
Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry
Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japan,...
$4,950.00
Special Price $3,712.50 save 25 %
-
01 Dec 2022  |  North America  |  Market Research
Global in Vitro Fertilization Services Growth Opportunities
Disruptive Technologies and Innovative Business Models are the Key Drivers in the IVF Services Industry
This study analyzes the in vitro fertility (IVF) services market across the globe. With infertility rates increasing across the world, assisted reproductive technologies (ART), including IVF, are gaining prominence. With technology advancements, the IVF process has undergone several modifications, with mainstream service providers such as fertility...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Mar 2023  |  North America  |  Customer Research
Global Laboratory Product Purchasing Trends, 2022–2023
End–user Perspectives on Laboratory Spending Reveals Modest 2023 Budget Increases Following robust 2022 Spending
Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey from October to November 2022 examining their laboratories’ product purchasing process in 2022 and expectations for 2023. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. The study presents year-over-...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Aug 2022  |  North America  |  Frost Radar
Frost Radar™: US Liquid Biopsy, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...
$4,950.00
Special Price $3,712.50 save 25 %